Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

SourceBio International 'uniquely positioned to help NHS reduce backlog as a partner'

SourceBio International 'uniquely positioned to help NHS reduce backlog as a partner'

SourceBio International PLC (AIM:SBI) (AIM:SBI, FRA:6J8) executive chairman Jay LeCoque joined Proactive's Katie Pilbeam to talk about their role in the COVID-19 pandemic and to tackle the huge treatment backlog.

The UK will set aside a further 5.4 billion pounds over the next six months to help its National Health Service cover additional costs and LeCoque says they are set up to help immediately.

The firm is a leading international provider of integrated state-of-the-art laboratory services and products with clients in the healthcare, clinical, life science research and biopharma industries, with a focus on improving patient diagnosis, management and care.

Also, their PCR Coronavirus (COVID-19) testing service was top of a short-list of four of “the best cheap day two Covid tests for travel” by the Which? consumer organisation.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK